NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

The new claim was approved based on third-party laboratory testing results that support Metrex’s portfolio of broad-spectrum surface disinfectants to be effective against SARS-CoV-2 according to EPA Product Performance Test Guidelines Disinfectants for Use on Environmental Surfaces, Guidance for Efficacy Testing (OCSPP 810.2200).

“Healthcare professionals find themselves working in rapidly-evolving and complex conditions that have increased the demands of infection control,” said James Chia, Director of Research and Development at Metrex. “The below Metrex’s surface disinfection products are effective against SARS-CoV-2, helping to give front-line workers peace of mind that our products are protecting their patients and themselves.”

The following Metrex products have been approved by the EPA for efficacy against

SARS-CoV-2 and are on the EPA list N for use against SARS-CoV-2:

  • CaviWipes 2.0
  • CaviWipes
  • CaviWipes1
  • CaviWipes Bleach
  • CaviCide
  • CaviCide1
  • MetriGuard
  • EnviroCide

CaviWipes and CaviCide surface disinfectant products clean and disinfect hard, non-porous, inanimate surfaces and non-critical medical device surfaces in hospitals, laboratories and other clinical care environments. Formulated to kill a broad spectrum of bacteria, viruses and pathogenic fungi quickly and efficiently, CaviWipes and CaviCide branded products support kill times from one to three minutes.

For more information, visit www.metrex.com.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X